...
首页> 外文期刊>Journal of Chemical Crystallography >Dichloro-{bis(Pyrazol-1-yl)}Palladium(II) Complexes: Structures of a DMSO Solvated Dichloro-{bis(3,5-Dimethylpyrazol-1-yl)Acetic Acid}Palladium(II) and Dichloro-{bis(3,5-Ditertbutylpyrazol-1-yl)Methane}Palladium(II)
【24h】

Dichloro-{bis(Pyrazol-1-yl)}Palladium(II) Complexes: Structures of a DMSO Solvated Dichloro-{bis(3,5-Dimethylpyrazol-1-yl)Acetic Acid}Palladium(II) and Dichloro-{bis(3,5-Ditertbutylpyrazol-1-yl)Methane}Palladium(II)

机译:二氯-{双(吡唑-1-基)}钯(II)配合物:DMSO溶剂化的二氯-{双(3,5-二甲基吡唑-1-基)乙酸}钯(II)和二氯-{bis的结构(3,5-二叔丁基吡唑-1-基)甲烷}钯(II)

获取原文
获取原文并翻译 | 示例
           

摘要

Two new palladium(II) complexes, dichloro-{bis(3,5-dimethylpyrazol-1-yl)acetic acid}palladium(II)PdCl2(3,5-Me2bpza)], (1) (3,5-Me2bpza = 3,5-dimethylpyrazol-1-yl)acetic acid) and dichloro-{bis(3,5-ditertbutylpyrazol-1-yl)acetic acid}palladium(II), [PdCl2(3,5-tBu2bpza)], (2a) [3,5- t Bu2bpza = 3,5-ditertiarybutylpyrazol-1-yl)acetic acid] complexes, were synthesized from the reactions of pyrazol-1-yl ligands with palladium salts. Attempts to crystallize 2a led to a hydrolyzed product, dichloro-{3,5-ditertbutylpyrazol-1-yl}palladium(II) (2b), in which the acetic acid moiety in the ligand backbone of 1 is lost. Both complexes 1 and 2b have been characterized by single-crystal X-ray crystallography. Both complexes crystallized in triclinic system (P ? 1 space group). The cell parameters are: complex 1 (a = 8.7960(14) ?, b = 16.238(2) ?, c = 16.430(2) ?, α = 78.038(10)°, β = 77.817(11)°, γ = 89.970(10)°) and complex 2b (a = 10.1492(2) ?, b = 12.4001(2) ?, c = 13.108(3) ?, α = 103.0690(10)°, β = 97.4120(10)°, γ = 107.2450(10)°). The asymmetric unit of 1 contains two crystallographic independent monomeric units of 1 and three molecules of DMSO solvent, whilst that of 2b has got one monomeric unit with one molecule of chloroform solvent.
机译:两种新的钯(II)配合物,二氯-{双(3,5-二甲基吡唑-1-基)乙酸}钯(II)PdCl2 (3,5-Me2 bpza)],( 1)(3,5-Me2 bpza = 3,5-二甲基吡唑-1-基)乙酸)和二氯-{双(3,5-二叔丁基吡唑-1-基)乙酸}钯(II) ,[PdCl2 (3,5-t Bu2 bpza)],(2a)[3,5- t Bu2 bpza = 3,5-由吡唑-1-基配体与钯盐反应合成了[二叔丁基吡唑-1-基]乙酸]配合物。尝试结晶2a导致水解产物二氯-{3,5-二叔丁基吡唑-1-基}钯(II)(2b),其中1的配体主链中的乙酸部分丢失。配合物1和2b都已通过单晶X射线晶体学表征。两种络合物均在三斜晶系中结晶(P = 1空间群)。像元参数为:复数1(a = 8.7960(14)α,b = 16.238(2)α,c = 16.430(2)α,α= 78.038(10)°,β= 77.817(11)°,γ= 89.970(10)°)和复数2b(a = 10.1492(2)α,b = 12.4001(2)α,c = 13.108(3)α,α= 103.0690(10)°,β= 97.4120(10)°, γ= 107.2450(10)°)。 1的不对称单元包含1的两个晶体学独立单体单元和3个DMSO溶剂分子,而2b的不对称单元具有1个分子单元和1个氯仿溶剂分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号